DigestRedComo funciona
Red
/
Empresas
Ir
No verificado

Ironwood Pharmaceuticals, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosSaludWeb y redes sociales

34 Comunicados de prensa

Ver todos los comunicados de prensa
06/08/2026
Web y redes sociales
Telefonía
Mercado de valores
Salud
Sanidad
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results
Fuente
Ironwood Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
30/07/2026
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Salud
Sanidad
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Ironwood Pharmaceuticals to Host Second Quarter 2026 Investor Update Call
Fuente
Ironwood Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
14/07/2026
Mercado laboral
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Medicina - Varios
Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients
Fuente
Ironwood Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
28/05/2026
Biotecnología
Farmacéutica
Salud
Web y redes sociales
Eventos
Ferias y Congresos
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
Fuente
Ironwood Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
27/05/2026
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
Industria
FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)
Fuente
Ironwood Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
07/05/2026
Web y redes sociales
Telefonía
Industria
Mercado de valores
Salud
Higiene alimentaria
Sanidad
Medicina - Varios
Farmacéutica
Biotecnología
Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance
Fuente
Ironwood Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
04/05/2026
Análisis de Mercados
Ciencia
Medicina - Varios
Fitness
Sanidad
Biotecnología
Farmacéutica
Salud
Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS)
Fuente
Ironwood Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
30/04/2026
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Biotecnología
Farmacéutica
Salud
Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call
Fuente
Ironwood Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
23/04/2026
Eventos
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026
Fuente
Ironwood Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
04/03/2026
Web y redes sociales
Eventos
Ferias y Congresos
Biotecnología
Farmacéutica
Salud
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
Fuente
Ironwood Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0